SemenBoost

Supplements

Omega-3 and male fertility

Omega-3 fats are part of sperm membranes. Trial evidence for semen changes is limited, and pregnancy benefit is not established.

Published
Modified
Clinician review
Not yet

Short answer

Sperm membranes contain omega-3 fatty acids, especially DHA. Observational studies and a small number of trials link fish-oil intake with semen measurements, particularly motility and morphology. That is limited parameter evidence. It is not evidence that an omega-3 capsule improves pregnancy or live birth.

Key takeaways

  • Eating fish and taking a concentrated capsule are different exposures.
  • Trial doses and EPA/DHA balances vary, so no dose is recommended here.
  • People on anticoagulants should check before using a high-dose fish oil.
  • No omega-3 product is affiliated or listed for sale.

What researchers are studying

DHA is a structural fat in the sperm head and tail. Diets low in omega-3 have been associated with poorer semen quality. Supplementation trials try to change that fatty-acid profile and then remeasure semen. A change in a blood or semen fatty-acid level is an intermediate finding, not a birth.

What studies show

A few randomised trials in men with infertility or abnormal semen have reported improvements in motility or in the proportion of normal forms after omega-3 supplementation for a few months. Samples are small. Not every trial agrees. SemenBoost does not quote a milligram target, because copying one trial’s capsule would look like a prescription.

Fertility outcomes

These trials are not live-birth trials. The antioxidant Cochrane review does not rescue omega-3 into a proven fertility drug. If you eat fish as part of the dietary pattern on the diet page, that is a food choice. It should not be upgraded into a claim that fish oil treats oligospermia.

Safety

Standard fish-oil doses are often tolerated. Higher doses can increase bleeding risk, which matters before surgery or with anticoagulant drugs, and can cause reflux. Algae-based DHA is the usual alternative for people who do not eat fish. Contaminant quality is a product issue SemenBoost has not audited, so no brand is recommended.

Evidence

Limited evidence

There is a biological rationale and limited trial evidence for semen parameters. Fertility outcomes are not demonstrated.

Semen parameters

Limited evidence

Small trials report motility or morphology changes. They are not consistent or large enough for a moderate rating.

Pregnancy and live birth

Insufficient evidence

Pregnancy and live birth have not been shown to improve because someone took omega-3.

A change in a semen measurement is not the same finding as a pregnancy or a live birth.

Related

Sources

  1. Antioxidants for male subfertility — Cochrane, 2022
  2. Fertility problems: assessment and treatment (NG257) — NICE, 2026
How this page was prepared

Drafted with automated research assistance and checked against the cited primary sources. A named clinician has not reviewed this page. Medical review is pending. Changes to reference values are not published automatically.